Veronique Demers-Mathieu

Dr. Veronique Demers-Mathieu

University California San diego
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
Veronique Demers-MathieuVeronique Demers-Mathieu
Veronique Demers-Mathieu
MUMark A. Underwood
Mark A. Underwood
Robert BeverlyRobert Beverly
Robert Beverly
SNSoeren Nielsen
Soeren Nielsen
DDDavid Dallas
David Dallas
Human milk provides immunoglobulins (Igs) that supplement the passive immune system of neonates; however, the extent of survival of these Igs during gastric digestion and whether this differs between preterm and term infants remains unknown. Human milk, and infant gastric samples at 2 h post-ingestion were collected from 15 preterm (23–32 week gestational age (GA)) mother-infant pairs and from 8 term (38–40 week of GA) mother-infant pairs within 7–98 days postnatal age. Samples were analyzed via ELISA for concentration of total IgA (secretory IgA (SIgA)/IgA), total secretory component (SC/SIgA/SIgM), total IgM (SIgM/IgM), and IgG as well as peptidomics. Total IgA concentration decreased by 60% from human milk to the preterm infant stomach and decreased by 48% in the term infant stomach. Total IgM and IgG concentrations decreased by 33% and 77%, respectively, from human milk to the term infant stomach but were stable in the preterm infant stomach. Release of peptides from all Ig isotypes in the term infant stomach was higher than in the preterm stomach. Overall, the stability of human milk Igs during gastric digestion is higher in preterm infant than in term infants, which could be beneficial for assisting the preterm infants’ immature immune system.

1 February 2013 in International Dairy Journal
Verified
Journal Article
Closed access
Veronique Demers-MathieuVeronique Demers-Mathieu
Veronique Demers-Mathieu
SGSylvie F. Gauthier
Sylvie F. Gauthier
MBMichel Britten
Michel Britten
IFIsmaïl Fliss
Ismaïl Fliss
GRGilles Robitaille
Gilles Robitaille
JJJulie Jean
Julie Jean

1 September 2020 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
Veronique Demers-MathieuVeronique Demers-Mathieu
Veronique Demers-Mathieu
DDDung M. Do
Dung M. Do
GMGabrielle B. Mathijssen
Gabrielle B. Mathijssen
DSDavid Sela
David Sela
ASAntti Seppo
Antti Seppo
EMElena Medo
Elena Medo

31 December 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
LMLe Barz Mélanie
Le Barz Mélanie
NDNoemie Daniel
Noemie Daniel
TVThibault V. Varin
Thibault V. Varin
SNSabrine Naimi
Sabrine Naimi
Veronique Demers-MathieuVeronique Demers-Mathieu
Veronique Demers-Mathieu
AMAndré Marette
André Marette
Given the growing evidence that gut dysfunction, including changes in gut microbiota composition, plays a critical role in the development of inflammation and metabolic diseases, the identification of novel probiotic bacteria with immunometabolic properties has recently attracted more attention. Herein, bacterial strains were first isolated from dairy products and human feces and then screened in vitro for their immunomodulatory activity. Five selected strains were further analyzed in vivo , using a mouse model of diet‐induced obesity. C57BL/6 mice were fed a high‐fat high‐sucrose diet, in combination with 1 of 3 Lactobacillus strains (Lb38, L. plantarum; L79, L. paracaseil casei; Lbl02, L. rhamnosus ) or Bifidobacterium strains (Bf26, Bfl41, 2 different strains of B. animalis ssp. lactis species) administered for 8 wk at 10 9 colony‐forming units/d. Whereas 3 strains showed only modest (Lb38, Bf26) or no (L79) effects, Lbl02 and Bfl41 reduced diet‐induced obesity, visceral fat accretion, and inflammation, concomitant with improvement of glucose tolerance and insulin sensitivity. Further analysis revealed that Lbl02 and Bf141 enhanced intestinal integrity markers in association with selective changes in gut microbiota composition. We have thus identified 2 new potential probiotic bacterial strains with immunometabolic properties to alleviate obesity development and associated metabolic disturbances.—Le Barz, M., Daniel, N., Varin, T. V., Naimi, S., Demers‐Mathieu, V., Pilon, G., Audy, J., Laurin, E., Roy, D., Urdaci, M. C., St‐Gelais, D., Fliss, I, Marette, A. In vivo screening of multiple bacterial strains identifies Lactobacillus rhamnosus Lbl02 and Bifidobacterium animalis ssp. lactis Bf 141 as probiotics that improve metabolic disorders in a mouse model of obesity. FASEB J. 33, 4921—4935 (2019). www.fasebj.org

24 April 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
Veronique Demers-MathieuVeronique Demers-Mathieu
Veronique Demers-Mathieu
RHRobert Huston
Robert Huston
AMAndi M. Markell
Andi M. Markell
EMElizabeth A. McCulley
Elizabeth A. McCulley
RMRachel L. Martin
Rachel L. Martin
DDDavid Dallas
David Dallas
Maternal antibody transfer to the newborn provides essential support for the infant’s naïve immune system. Preterm infants normally receive maternal antibodies through mother’s own breast milk (MBM) or, when mothers are unable to provide all the milk required, donor breast milk (DBM). DBM is pasteurized and exposed to several freeze–thaw cycles, which could reduce intact antibody concentration and the antibody’s resistance to digestion within the infant. Whether concentrations of antibodies in MBM and DBM differ and whether their survival across digestion in preterm infants differs remains unknown. Feed (MBM or DBM), gastric contents (MBM or DBM at 1-h post-ingestion) and stool samples (collected after a mix of MBM and DBM feeding) were collected from 20 preterm (26–36 weeks gestational age) mother–infant pairs at 8–9 and 21–22 days of postnatal age. Samples were analyzed via ELISA for the concentration of secretory IgA (SIgA), total IgA (SIgA/IgA), total IgM (SIgM/IgM) and IgG. Total IgA, SIgA, total IgM and IgG concentrations were 55.0%, 71.6%, 98.4% and 41.1% higher in MBM than in DBM, and were 49.8%, 32.7%, 73.9% and 39.7% higher in gastric contents when infants were fed with MBM than when infants were fed DBM, respectively. All maternal antibody isotypes present in breast milk were detected in the infant stools, of which IgA (not sIgA) was the most abundant.

1 May 2018 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
Veronique Demers-MathieuVeronique Demers-Mathieu
Veronique Demers-Mathieu
YQYunyao Qu
Yunyao Qu
MUMark A. Underwood
Mark A. Underwood
RBRobyn Borghese
Robyn Borghese
DDDavid Dallas
David Dallas